Syros Announces Appointment of Alice T. Shaw to its Board of Directors

80

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, today announced the appointment of Alice Tsang Shaw, M.D., Ph.D., to the Company’s Board of Directors. Dr. Shaw is a highly respected oncologist and recognized leader in translational medicine and the development of targeted cancer therapies. “Alice is a brilliant doctor and researcher, with a proven record of bridging….

 

http://www.businesswire.com/news/home/20190612005074/en/Syros-Announces-Appointment-Alice-T.-Shaw-Board